Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.

Biotechnology

Education

Samsara Therapeutics

Samsara Therapeutics' headquarters in Oxford, United Kingdom

Jens Eckstein

Marija Zecevic

Warren Galloway

Guido Kroemer

Didac Carmona-Gutierrez

Michael Schlossmacher

Susan Perlman

Christian Behl

Ed Tate

The Scientific Team at Samsara Therapeutics is responsible for conducting cutting-edge research to discover and optimize therapeutic compounds that enhance autophagy. They lead efforts in in vivo validation, leveraging their expertise in biology and chemistry to identify and develop treatments for rare genetic and neurodegenerative diseases. This team collaborates closely to push the boundaries of science and extend healthy lifespans through innovative drug discovery.

Scientific Team

The Leadership Team at Samsara Therapeutics is responsible for setting the strategic vision and direction of the company, guiding research and development efforts in the area of rare genetic and neurodegenerative diseases. This team, composed of key executives and scientific leaders, collaborates to drive innovation, oversee the development of therapeutic compounds, and ensure alignment of scientific and business objectives to achieve the company's mission of extending healthy lifespans.

Samsara Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Samsara Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies